Immunization with a dominant-negative recombinant Herpes Simplex Virus (HSV) type 1 protects against HSV-2 genital disease in guinea pigs

Immunization with a dominant-negative recombinant Herpes Simplex Virus (HSV) type 1 protects against HSV-2 genital disease in guinea pigs

<p>Abstract</p> <p>Background</p> <p>CJ9-gD is a novel dominant-negative recombinant herpes simplex virus type 1 (HSV-1) that is completely replication-defective, cannot establish detectable latent infection <it>in </it>vivo, and expresses high levels of the...

Full description

Bibliographic Details
Main Authors:	Brans Richard, Yao Feng
Format:	Article
Language:	English
Published:	BMC 2010-06-01
Series:	BMC Microbiology
Online Access:	http://www.biomedcentral.com/1471-2180/10/163

Similar Items

A herpes simplex virus 2 (HSV-2) glycoprotein D-expressing nonreplicating dominant-negative HSV-2 virus vaccine is superior to a gD2 subunit vaccine against HSV-2 genital infection in guinea pigs.
by: Pengwei Zhang, et al.
Published: (2014-01-01)

An Adenovirus-Based Recombinant Herpes Simplex Virus 2 (HSV-2) Therapeutic Vaccine Is Highly Protective against Acute and Recurrent HSV-2 Disease in a Guinea Pig Model
by: Mingming Wan, et al.
Published: (2023-01-01)

Virus-specific immune memory at peripheral sites of herpes simplex virus type 2 (HSV-2) infection in guinea pigs.
by: Jingya Xia, et al.
Published: (2014-01-01)

Herpes simplex virus type 2 trivalent protein vaccine containing glycoproteins C, D and E protects guinea pigs against HSV-1 genital infection
by: Kevin Egan, et al.
Published: (2020-09-01)

Assessment of Two Novel Live-Attenuated Vaccine Candidates for Herpes Simplex Virus 2 (HSV-2) in Guinea Pigs
by: Jonathan D. Joyce, et al.
Published: (2021-03-01)

Herpes Simplex Virus Mistyping due to HSV-1 × HSV-2 Interspecies Recombination in Viral Gene Encoding Glycoprotein B
by: Amanda M. Casto, et al.
Published: (2020-08-01)

Herpes simplex virus 2 (HSV-2) infected cell proteins are among the most dominant antigens of a live-attenuated HSV-2 vaccine.
by: Joshua J Geltz, et al.
Published: (2015-01-01)

Immunogenicity, protective efficacy, and non-replicative status of the HSV-2 vaccine candidate HSV529 in mice and guinea pigs.
by: Marie-Clotilde Bernard, et al.
Published: (2015-01-01)

Reactivation of Herpes Simplex Virus (HSV) from Latency in Response to Neuronal Hyperexcitability
by: Sean Cuddy, et al.
Published: (2020-06-01)

Prevalence of Herpes Simplex Virus Type 1 and 2 (HSV-1 and HSV-2) in the Women with Breast Cancer by Multiplex-PCR method
by: Fatemeh Kaveh, et al.
Published: (2018-05-01)

Enhancement of Herpes Simplex Virus (HSV) Infection by Seminal Plasma and Semen Amyloids Implicates a New Target for the Prevention of HSV Infection
by: Lilith Torres, et al.
Published: (2015-04-01)

The population impact of herpes simplex virus type 2 (HSV-2) vaccination on the incidence of HSV-2, HIV and genital ulcer disease in South Africa: a mathematical modelling studyResearch in context
by: Jack Stone, et al.
Published: (2023-04-01)

Duration of protection from live attenuated vs. sub unit HSV-2 vaccines in the guinea pig model of genital herpes: Reassessing efficacy using endpoints from clinical trials.
by: David I Bernstein, et al.
Published: (2019-01-01)

Optimal Control Strategy on the Transmission Dynamics of Herpes Simplex Virus-II (HSV-II)
by: Eshetu Dadi Gurmu, et al.
Published: (2021-01-01)

Host Intrinsic and Innate Intracellular Immunity During Herpes Simplex Virus Type 1 (HSV-1) Infection
by: Thamir Alandijany, et al.
Published: (2019-11-01)

An attenuated herpes simplex virus type 1 (HSV1) encoding the HIV-1 Tat protein protects mice from a deadly mucosal HSV1 challenge.
by: Mariaconcetta Sicurella, et al.
Published: (2014-01-01)

An HSV-2 nucleoside-modified mRNA genital herpes vaccine containing glycoproteins gC, gD, and gE protects mice against HSV-1 genital lesions and latent infection.
by: Kevin P Egan, et al.
Published: (2020-07-01)

The Effect of Herpes Simplex Virus-Type-1 (HSV-1) Oncolytic Immunotherapy on the Tumor Microenvironment
by: Ifeanyi Kingsley Uche, et al.
Published: (2021-06-01)

Diagnosis and quantitative detection of HSV DNA in samples from patients with suspected herpes simplex encephalitis
by: Mazyar Ziyaeyan, et al.

Association between Herpes Simplex virus type 2 (HSV 2) and bad obstetric outcomes
by: Hala Mohamed Majeed Hassan, et al.
Published: (2014-01-01)

Herpes Simplex Virus-type1 (HSV-1) Impairs DNA Repair in Cortical Neurons
by: Giovanna De Chiara, et al.
Published: (2016-10-01)

Diagnosis and quantitative detection of HSV DNA in samples from patients with suspected herpes simplex encephalitis
by: Mazyar Ziyaeyan, Ph.D., et al.
Published: (2011-05-01)

Protection of mice against lethal challenge with herpes simplex virus by vaccination with an adenovirus vector expressing HSV glycoprotein B.
by: McDermott, MR, et al.
Published: (1989)

The Roles of Host and Viral Antibody Fc Receptors in Herpes Simplex Virus (HSV) and Human Cytomegalovirus (HCMV) Infections and Immunity
by: Jennifer A. Jenks, et al.
Published: (2019-09-01)

Novel Adjuvant S-540956 Targets Lymph Nodes and Reduces Genital Recurrences and Vaginal Shedding of HSV-2 DNA When Administered with HSV-2 Glycoprotein D as a Therapeutic Vaccine in Guinea Pigs
by: Sita Awasthi, et al.
Published: (2023-05-01)

Potentiated virucidal activity of pomegranate rind extract (PRE) and punicalagin against Herpes simplex virus (HSV) when co-administered with zinc (II) ions, and antiviral activity of PRE against HSV and aciclovir-resistant HSV.
by: David M J Houston, et al.
Published: (2017-01-01)

Correction: Potentiated virucidal activity of pomegranate rind extract (PRE) and punicalagin against Herpes simplex virus (HSV) when co-administered with zinc (II) ions, and antiviral activity of PRE against HSV and aciclovir-resistant HSV.
by: David M J Houston, et al.
Published: (2017-01-01)

The Antiviral Potential of Iranian Herbal Pharmacopoeia (IHP) on Herpes Simplex Viruses (HSV): A Review Article
by: Shahin Gavanji
Published: (2022-07-01)

Effect of genital herpes on cervicovaginal HIV shedding in women co-infected with HIV AND HSV-2 in Tanzania.
by: Jim Todd, et al.
Published: (2013-01-01)

Urethral Orifice Genital Herpes Caused by HSV-1 in a Female Patient: A Case Report
by: Jia-Yi Yang, et al.
Published: (2021-06-01)

An HSV-2 Trivalent Vaccine Is Immunogenic in Rhesus Macaques and Highly Efficacious in Guinea Pigs.
by: Sita Awasthi, et al.
Published: (2017-01-01)

Occurrence of HSV with other microorganisms in female genital infection
by: Al-Omar S. Layla, et al.
Published: (2005-06-01)

Efficacy of Systemically Administered Retargeted Oncolytic Herpes Simplex Viruses—Clearance and Biodistribution in Naïve and HSV-Preimmune Mice
by: Andrea Vannini, et al.
Published: (2023-08-01)

Incidental Detection of Hairy Cell Leukaemia with Herpes Simplex Virus (HSV) Related Lip Ulcer Mimicking Carcinoma
by: Pallavi Agrawal, et al.
Published: (2016-08-01)

Viral risk factor for seizures: Pathobiology of dynorphin in herpes simplex viral (HSV-1) seizures in an animal model
by: Marylou V. Solbrig, et al.
Published: (2006-09-01)

Development and Assessment of Herpes Simplex Virus Type 1 (HSV-1) Amplicon Vectors with Sensory Neuron-Selective Promoters
by: Charles Joussain, et al.
Published: (2022-07-01)

Role of IL-4 in an experimental model of encephalitis induced by intracranial inoculation of herpes simplex virus-1 (HSV-1)
by: Márcia Carvalho Vilela, et al.
Published: (2011-04-01)

Reactive oxygen species drive herpes simplex virus (HSV)-1-induced proinflammatory cytokine production by murine microglia
by: Lokensgard James R, et al.
Published: (2011-09-01)

Functional Overexpression of Vomeronasal Receptors Using a Herpes Simplex Virus Type 1 (HSV-1)-Derived Amplicon.
by: Benjamin Stein, et al.
Published: (2016-01-01)

Antibodies to Crucial Epitopes on HSV-2 Glycoprotein D as a Guide to Dosing an mRNA Genital Herpes Vaccine
by: Lauren M. Hook, et al.
Published: (2022-03-01)